Publicaciones en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (145)

2024

  1. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function

    FEBS Journal

  2. Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

    Antioxidants, Vol. 13, Núm. 9

  3. Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects

    Chimia, Vol. 78, Núm. 7-8, pp. 499-512

  4. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

  5. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline

    British Journal of Pharmacology

  6. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

    Journal of Neuroscience, Vol. 44, Núm. 39

  7. Interleukin-6 as a prognostic marker in acute renal injury and its klotho-dependent regulation

    Nefrologia

  8. Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Biomedicine and Pharmacotherapy, Vol. 174

  9. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

  10. The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors

    Redox Biology, Vol. 77

  11. Violet Light Effects on the Circadian Rest–Activity Rhythm and the Visual System

    Clocks and Sleep, Vol. 6, Núm. 3, pp. 433-445

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  3. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

    Neuropharmacology, Vol. 237

  4. Endocannabinoid signaling in glioma

    GLIA, Vol. 71, Núm. 1, pp. 127-138

  5. Endocannabinoid-Binding Receptors as Drug Targets

    Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

  6. Fatty acids fuelling astroglia and beyond

    Nature Metabolism

  7. Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice

    Journal of neuroinflammation, Vol. 20, Núm. 1, pp. 108

  8. Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  9. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

    Neuropharmacology, Vol. 240